Back to discover
Disease

Sepsis-Associated Encephalopathy

Clinical development underwayEmerging researchRising momentum
5
Publications
1
Clinical trials
2
Related conditions
2025
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

Targeted rescue of synaptic plasticity improves cognitive decline in sepsis-associated encephalopathy.

Research2024-05-23Molecular therapy : the journal of the American Society of Gene Therapy

Blood-Brain Barrier Disruption by Lipopolysaccharide and Sepsis-Associated Encephalopathy.

Research2021-11-04Frontiers in cellular and infection microbiology

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

No activity recorded in this window. Try a wider timeframe.

Clinical trials

1 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme
1
All trials
0
Active
0
Late-stage
1
Completed

Research activity

5 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Publications over time
20212025
Most influential
Recent publications
Major themes8
  • Sepsis-Associated Encephalopathy4
  • Cognitive Dysfunction2
  • Hippocampus2
  • Neuronal Plasticity2
  • Sepsis2
  • Brain Diseases1
  • Brain-Derived Neurotrophic Factor1
  • Cytoskeletal Proteins1
Leading journals5
  • CNS neuroscience & therapeutics1
  • Critical care medicine1
  • Current neuropharmacology1
  • Frontiers in cellular and infection microbiology1
  • Molecular therapy : the journal of the American Society of Gene Therapy1
Leading researchers8
  • Battaglini D1
  • Bauer M1
  • Blaess M1
  • Chai X1
  • Cho SM1
  • Chung HY1
  • Claus RA1
  • Diao YG1
Affiliations (unnormalised)6
  • Air Force Medical Center1
  • Brigham and Women's Hospital1
  • Center for Sepsis Control and Care1
  • Department of Clinical Medicine1
  • General Hospital of Northern Theater Command1
  • Griffith University School of Medicine1

Related conditions

2 matches

Diseases frequently studied alongside this one. Number shows shared papers.

Disease profile

A grounded synthesis of the condition — overview, causes, mechanism, risk factors and current standard of care.

Overview

Sepsis-associated encephalopathy is an acute neurological dysfunction that occurs during severe sepsis without direct infection of the brain. It is characterized by systemic inflammation and disruption of the blood-brain barrier. The literature also describes it as a form of cognitive and psychological impairment that can occur without central nervous system infection or structural brain injury.

Causes

The grounding supports sepsis as the underlying condition and indicates that lipopolysaccharide from Gram-negative bacteria can contribute by damaging the blood-brain barrier. No additional specific causes are supported beyond severe sepsis and related inflammatory injury.

Pathophysiology

The central mechanism described is blood-brain barrier perturbation, which allows inflammatory factors and neurotoxins to enter the brain and damage neural tissue. This can activate brain immune cells and amplify inflammatory responses, creating a vicious cycle of further barrier injury. The literature also points to glial cell activation and altered synaptic plasticity as important parts of the pathological process.

Risk factors

Severe sepsis is the main supported risk context for this syndrome. The supplied grounding does not support additional specific risk factors.

Current standard of care

The supplied grounding supports treatment only at a broad modality level and does not provide a specific standard regimen. It indicates that the literature covers therapy, but no particular drug class or intervention is explicitly supported in the provided material. Neurologic monitoring is discussed in the literature, but not as a treatment standard.

AI-generated summary grounded in MeSH and 3 peer-reviewed sources. Informational only — not medical advice. Generated 2026-07-07.

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Acute neurological dysfunction during severe SEPSIS in the absence of direct brain infection characterized by systemic inflammation and BLOOD BRAIN BARRIER perturbation.

References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.